PHGE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.01%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,249.20

BiomX Insider Trading History Chart

BiomX Share Price & Price History

^$0.87

▼ -0.01 (-1.13%)

As of 10/28/2024 01:00 AM ET

Days: 30 | 90 | 365

The most serious warning of my career

From Porter & Company | Ad

With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.

Click here now to grab your seat now.

BiomX Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2024	Israel Biofund Gp Limi Orbimed	Major Shareholder	Sell	2,434	$3.80	$9,249.20	1,377,365
5/22/2023	Assaf Oron	Insider	Buy	319	$2.70	$861.30	1,091
2/27/2023	Israel Biofund Gp Limi Orbimed	Major Shareholder	Buy	34,800	$2.40	$83,520.00	316,148
11/4/2022	Chidozie Ugwumba	Major Shareholder	Sell	150	$3.80	$570.00	299,702
11/2/2022	Chidozie Ugwumba	Major Shareholder	Sell	241	$3.60	$867.60	300,052
10/31/2022	Chidozie Ugwumba	Major Shareholder	Sell	330	$3.70	$1,221.00	300,424
10/28/2022	Chidozie Ugwumba	Major Shareholder	Sell	152	$3.60	$547.20	300,754
10/26/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,250	$3.50	$4,375.00	301,057
10/24/2022	Chidozie Ugwumba	Major Shareholder	Sell	590	$3.50	$2,065.00	302,614
10/21/2022	Chidozie Ugwumba	Major Shareholder	Sell	540	$3.70	$1,998.00	303,204
10/19/2022	Chidozie Ugwumba	Major Shareholder	Sell	450	$3.70	$1,665.00	304,408
10/17/2022	Chidozie Ugwumba	Major Shareholder	Sell	809	$3.40	$2,750.60	306,388
10/14/2022	Chidozie Ugwumba	Major Shareholder	Sell	342	$3.30	$1,128.60	307,198
10/12/2022	Chidozie Ugwumba	Major Shareholder	Sell	970	$3.30	$3,201.00	308,671
10/10/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,004	$3.30	$3,313.20	310,240
10/7/2022	Chidozie Ugwumba	Major Shareholder	Sell	2,470	$3.60	$8,892.00	311,244
10/5/2022	Chidozie Ugwumba	Major Shareholder	Sell	4,678	$4.30	$20,115.40	316,225
10/3/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,502	$3.30	$4,956.60	322,823
9/30/2022	Chidozie Ugwumba	Major Shareholder	Sell	866	$3.60	$3,117.60	324,325
9/28/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,564	$3.30	$5,161.20	325,522
9/26/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,752	$3.50	$6,132.00	327,573
9/23/2022	Chidozie Ugwumba	Major Shareholder	Sell	530	$3.70	$1,961.00	329,326
9/21/2022	Chidozie Ugwumba	Major Shareholder	Sell	557	$4.30	$2,395.10	331,595
9/19/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,387	$4.80	$6,657.60	333,215
9/16/2022	Chidozie Ugwumba	Major Shareholder	Sell	320	$5.10	$1,632.00	334,602
9/14/2022	Chidozie Ugwumba	Major Shareholder	Sell	230	$5.20	$1,196.00	335,312
9/12/2022	Chidozie Ugwumba	Major Shareholder	Sell	170	$5.40	$918.00	335,762
9/8/2022	Chidozie Ugwumba	Major Shareholder	Sell	459	$5.20	$2,386.80	337,254
9/6/2022	Chidozie Ugwumba	Major Shareholder	Sell	640	$5.50	$3,520.00	338,598
9/2/2022	Chidozie Ugwumba	Major Shareholder	Sell	200	$5.50	$1,100.00	339,238
8/31/2022	Chidozie Ugwumba	Major Shareholder	Sell	454	$5.50	$2,497.00	340,268
8/29/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,153	$5.70	$6,572.10	342,071
8/26/2022	Chidozie Ugwumba	Major Shareholder	Sell	6,062	$6.20	$37,584.40	343,224
8/24/2022	Chidozie Ugwumba	Major Shareholder	Sell	866	$6.50	$5,629.00	351,982
8/22/2022	Chidozie Ugwumba	Major Shareholder	Sell	500	$6.60	$3,300.00	353,438
8/19/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,460	$6.40	$9,344.00	353,938
8/17/2022	Chidozie Ugwumba	Major Shareholder	Sell	2,133	$6.90	$14,717.70	356,174
8/15/2022	Chidozie Ugwumba	Major Shareholder	Sell	720	$7.50	$5,400.00	359,164
8/12/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,140	$7.30	$8,322.00	359,884
8/10/2022	Chidozie Ugwumba	Major Shareholder	Sell	1,776	$7.40	$13,142.40	362,007

Notice: Major payout due November 19th - are you on the list?

From Behind the Markets | Ad

On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's part of a unique strategy which has nothing to do with risky investments like options, cryptos or forex. And while it might sound crazy...

Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for BiomX (NYSEMKT:PHGE)

40.57% of BiomX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BiomX Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2024	Ikarian Capital LLC	10,817,327	$4.87M	0.5%	N/A	19.590%
5/10/2024	Johnson & Johnson	1,923,201	$0.87M	0.0%	-9.9%	3.483%
11/3/2022	Royce & Associates LP	158,655	$54K	0.0%	-51.7%	0.529%
5/5/2022	Royce & Associates LP	320,655	$0.62M	0.0%	+200.5%	1.077%
2/7/2022	Royce & Associates LP	106,696	$0.17M	0.0%	-52.7%	0.373%
11/12/2021	Johnson & Johnson	2,133,402	$6.53M	0.6%	N/A	7.568%
10/26/2021	Taylor Wealth Management Partners	40,098	$91K	0.0%	-44.3%	0.142%
8/17/2021	Millennium Management LLC	427,702	$2.34M	0.0%	-5.9%	1.758%
8/17/2021	Bridgeway Capital Management LLC	104,000	$0.57M	0.0%	-15.4%	0.427%
5/18/2021	Millennium Management LLC	454,377	$3.24M	0.0%	-1.2%	1.954%
5/18/2021	Jane Street Group LLC	25,365	$0.18M	0.0%	N/A	0.109%
5/13/2021	Renaissance Technologies LLC	36,200	$0.26M	0.0%	N/A	0.156%
5/10/2021	Royce & Associates LP	359,000	$2.56M	0.0%	N/A	1.544%

Data available starting January 2016

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Today's Range

Now: $0.87

$0.87

$0.90

50 Day Range

MA: $1.05

$0.14

$1.48

52 Week Range

Now: $0.87

Volume

27,301 shs

Average Volume

68,601 shs

Market Capitalization

$60.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of BiomX?: BiomX's top insider shareholders include:
Israel Biofund Gp Limi Orbimed (Major Shareholder)
Chidozie Ugwumba (Major Shareholder)
Assaf Oron (Insider)
Learn More about top insider investors at BiomX.